Wird geladen...
In Vivo Selection of Respiratory Syncytial Viruses Resistant to Palivizumab
Palivizumab (PZ) is the only monoclonal antibody currently available for use in humans against an infectious disease. PZ is administered prophylactically for respiratory syncytial virus (RSV) infections. RSV selected in cell culture for growth in the presence of PZ develops F gene mutations and can...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology
2005
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1061530/ https://ncbi.nlm.nih.gov/pubmed/15767398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.79.7.3962-3968.2005 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|